开云app官网登录入口网页版-官方正版

#贝福替尼#

0篇内容 | 685人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2225092, encodeId=cdb7222509203, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#贝福替尼#</a>, objectTitle=连线WCLC | 凯赛携手靶向耐药新策略，重磅数据亮相2024 WCLC, objectType=article, longId=842618, objectId=e0088426180d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720503095993_8538692.jpg, objectUrl=/article/show_article.do?id=e0088426180d, replyNumber=0, likeNumber=11, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e0088426180d, moduleTitle=连线WCLC | 凯赛携手靶向耐药新策略，重磅数据亮相2024 WCLC, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e0088426180d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225100, encodeId=d1052225100e4, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=de711863ed3' target=_blank style='color:#2F92EE;'>#WCLC#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#贝福替尼#</a>, objectTitle=2024WCLC揭示IBIO-102研究最新突破：凯赛序贯显著延长肺癌生存, objectType=article, longId=842628, objectId=dc46842628de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240905/1725498482877_8538692.jpg, objectUrl=/article/show_article.do?id=dc46842628de, replyNumber=0, likeNumber=15, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dc46842628de, moduleTitle=2024WCLC揭示IBIO-102研究最新突破：凯赛序贯显著延长肺癌生存, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=dc46842628de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221679, encodeId=5e1122216e97f, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#贝福替尼#</a>, objectTitle=从试验数据到临床实战：贝福替尼II期最终总生存率见刊Lung Cancer, objectType=article, longId=839982, objectId=adc7839982dd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720668862484_5579292.png, objectUrl=/article/show_article.do?id=adc7839982dd, replyNumber=0, likeNumber=60, createdTime=2024-08-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=adc7839982dd, moduleTitle=从试验数据到临床实战：贝福替尼II期最终总生存率见刊Lung Cancer, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=adc7839982dd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174227, encodeId=263021e422787, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=4c496569c8' target=_blank style='color:#2F92EE;'>#EGFR#</a> <a href='/topic/show?id=011941548ad' target=_blank style='color:#2F92EE;'>#埃克替尼#</a> <a href='/topic/show?id=c0501084e91d' target=_blank style='color:#2F92EE;'>#贝福替尼#</a>, objectTitle=贝家讲坛 | 聚焦脑转移与共突变人群，原研EGFR-TKI贝福替尼与埃克替尼先「卷」为敬, objectType=article, longId=804440, objectId=cc00804440fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=cc00804440fd, replyNumber=0, likeNumber=128, createdTime=2023-12-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cc00804440fd, moduleTitle=贝家讲坛 | 聚焦脑转移与共突变人群，原研EGFR-TKI贝福替尼与埃克替尼先「卷」为敬, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=cc00804440fd)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

非小细胞肺癌 EGFR 埃克替尼贝福替尼

2023-12-11发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #贝福替尼#

连线WCLC | 凯赛携手靶向耐药新策略，重磅数据亮相2024 WCLC

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#NSCLC# #WCLC# #贝福替尼#

2024WCLC揭示IBIO-102研究最新突破：凯赛序贯显著延长肺癌生存

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #贝福替尼#

从试验数据到临床实战：贝福替尼II期最终总生存率见刊Lung Cancer

2024-08-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #EGFR# #埃克替尼# #贝福替尼#

贝家讲坛 | 聚焦脑转移与共突变人群，原研EGFR-TKI贝福替尼与埃克替尼先「卷」为敬

2023-12-11发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务